Catalyzing Access to New Prevention Products to Stop HIV
Catalyzing Access to New Prevention Products to Stop HIV (CATALYST) is MOSAIC’s flagship product introduction study. The study will provide and assess an enhanced service delivery package that includes oral PrEP, PrEP ring, and injectable cabotegravir. The package of products and services for PrEP will be provided to women at PEPFAR delivery sites in Kenya, Lesotho, South Africa, Uganda and Zimbabwe. The CATALYST study will also use quality improvement methods to refine the program and identify a core package for delivering PrEP choice.
For any additional information or questions about CATALYST, please contact the Research Operations Group (ROG) at [email protected].